Kory James Wentworth, Chief Financial Officer at Entrada Therapeutics, Inc. (TRDA), sold 20,184 shares at $13.08 ($264K) on 2022-08-19, disclosed to the SEC on 2022-08-23.
Open-market sale of $264k TRDA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.08 | 8,529 | $112K | 42.3% |
| 2 | $13.08 | 8,529 | $112K | 42.3% |
| 3 | $13.00 | 217 | $3K | 1.1% |
| 4 | $13.09 | 2,909 | $38K | 14.4% |
| Total | $13.08 avg | 20,184 | $264K | 100% |
| Filing → |
| TRDA | SELL | 2026-03-06 | $196K | — | Filing → |
| TRDA | SELL | 2025-11-24 | $178K | — | Filing → |
| TRDA | SELL | 2025-03-19 | $19K | — | Filing → |